ANAPLASTIC OLIGODENDROGLIOMA
Clinical trials for ANAPLASTIC OLIGODENDROGLIOMA explained in plain language.
Never miss a new study
Get alerted when new ANAPLASTIC OLIGODENDROGLIOMA trials appear
Sign up with your email to follow new studies for ANAPLASTIC OLIGODENDROGLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes on brain tumors: first human trial begins
Disease control Recruiting nowThis early-stage trial tests an oral drug called ONC206 in adults with brain tumors that have come back. The main goal is to find the safest dose and understand side effects. About 102 participants will receive the drug weekly or multiple days per week.
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Kids' brain tumor drug combo gets Long-Term safety check
Disease control Recruiting nowThis study follows children who previously took dabrafenib and/or trametinib for certain brain tumors. It aims to see how safe these drugs are over the long term by tracking side effects and monitoring growth. About 163 children are enrolled, and the study is no longer recruiting…
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New combo therapy targets aggressive brain tumors in phase 2 trial
Disease control Recruiting nowThis study tests a more intense treatment for a fast-growing type of brain cancer called IDH wildtype glioma. It combines higher doses of radiation with the chemotherapy drug temozolomide to try to stop the tumor from growing longer. The trial will enroll 40 adults with this spec…
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New combo aims to fight aggressive brain tumors that have come back
Disease control Recruiting nowThis early-phase study tests a new two-drug combination for adults whose high-grade glioma (a fast-growing brain tumor) has returned after standard treatments. The drugs are temozolomide (given in low, frequent doses) and abexinostat (an experimental pill). The main goal is to fi…
Matched conditions: ANAPLASTIC OLIGODENDROGLIOMA
Phase: PHASE1 • Sponsor: University of Nebraska • Aim: Disease control
Last updated May 11, 2026 20:48 UTC